Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Comment by luvhorseson May 18, 2020 11:15am
100 Views
Post# 31042100

RE:RE:RE:RE:RE:RE:That's the difference

RE:RE:RE:RE:RE:RE:That's the differenceLong story short....before AGN became "AGN", it was trading under the symbol 'BTH'.  Now, back then BTH was going to be a pot breathlyzer.  The company touted this during the pot sector and people (including myself) bought into their story.  (I bought in @ about .30.) and it was making a move as it reached a high of .42. Then it was all funken junk afterwards....price kept falling.  Then the company pulled the rug from under us as investors...did a 10 for 1 reverse funken split!!  And BTH never recovered.

About a few months later (actually quite a few months later) while the price was tanking even with the split, the company changed course and changed it's sybmol to 'AGN'.  Now, this was when BTH/AGN was probably about .05....that's right...funken .05!!!   It feel even lower to .02....at the time, I said, '$crew it, AGN wasn't worth selling...and it's not a loss till you sell it'.  Well, as AGN started coming out with new releases about their products and they were making noises in the medical fields with their results, I started getting interesting in this gem. When AGN started moving back in Feb....albeit, quietly, I took a liking to them.  decided to buy back an entire position to break even with my BTH holdings and when I saw that they were listed as c.AGN.wt as well, I bought a ton more.  And as they say...the rest is history!! 

Now AMG was here when I was here...in fact, it would just be me answering his questions or him answering mine!!  he's a good B A $ t a r d...very knowledgable as well!






Bullboard Posts